NeuroVive Pharmaceutical AB , a company in mitochondrial medicine announced that research resources and activities of the Taiwan-based subsidiary redirected...
Read moreJitsubo Co., Ltd. announced that it has executed the joint development and license agreement with a Japanese pharmaceutical company (undisclosed)...
Read moreThe agreement will benefit clinical trials, delivering Suvoda’s cutting edge IRT/IWRS technology for subject randomization and trial supply management integrated...
Read moreThe COPD Foundation-sponsored COPD Biomarker Qualification Consortium announced that it has partnered with the Bio Techne Cor, a manufacturer of...
Read moreAdaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the...
Read moreSenhwa Biosciences, Inc. announced that the U.S. FDA has granted Orphan Drug Designation to CX-4945 for the treatment of cholangiocarcinoma....
Read moreSanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known...
Read moreThe US FDA has approved Synjardy® XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When...
Read moreSun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) and Israel-based Moebius Medical have entered into an exclusive...
Read moreRespiratorius AB (publ.) has received Orphan Drug Designation for its drug candidate VAL001 following a decision by the European Commission....
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.